US2020375729A1PendingUtilityA1

Systems and methods for transcatheter aortic valve treatment

Assignee: SILK ROAD MEDICAL INCPriority: Feb 26, 2010Filed: Aug 21, 2020Published: Dec 3, 2020
Est. expiryFeb 26, 2030(~3.6 yrs left)· nominal 20-yr term from priority
A61F 2/2436A61F 2/013A61F 2002/018A61F 2230/0067A61F 2230/0008A61F 2230/0006A61F 2220/0008A61F 2220/0075A61B 2017/0409A61B 17/0401A61B 17/12122A61F 2/2427A61F 2/24
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Devices and methods are configured to allow transcervical or subclavian access via the common carotid artery to the native aortic valve, and implantation of a prosthetic aortic valve into the heart. The devices and methods also provide means for embolic protection during such an endovascular aortic valve implantation procedure.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating an aortic valve of a heart, the method comprising:
 forming a penetration at the neck of a patient in a wall of a common carotid artery;   introducing an arterial access sheath through the penetration, the arterial access sheath comprising a proximal end region, a distal end region, and an internal lumen extending between the proximal end region and the distal end region, the proximal end region coupled to a hemostatic device and the distal end region coupled to an embolic protection filter in a collapsed state configured for insertion to a vessel;   deploying the embolic protection filter from the collapsed state to a deployed state configured to deploy across a diameter of the vessel to capture embolic material flowing through the vessel to provide embolic protection;   inserting a guide wire across a native aortic valve; and   introducing a prosthetic valve through the arterial access sheath and deploying the prosthetic valve at or near the position of the native aortic valve.   
     
     
         2 . A method as in  claim 1 , further comprising:
 collapsing the embolic protection filter;   removing the arterial access sheath; and   closing the penetration.   
     
     
         3 . A method as in  claim 2 , wherein the embolic protection filter is withdrawn or removed prior to removing the arterial access sheath. 
     
     
         4 . A method as in  claim 1 , further comprising applying a closure device at a site of the penetration before introducing the arterial access sheath through the penetration. 
     
     
         5 . A method as in  claim 4 , wherein the closure device comprises a suture-based closure device. 
     
     
         6 . A method as in  claim 1 , wherein the vessel is the ascending aorta or a region of the aortic arch. 
     
     
         7 . A method as in  claim 1 , further comprising occluding the common carotid artery. 
     
     
         8 . A method as in  claim 7 , further comprising establishing blood flow from the common carotid artery such that blood flows into the internal lumen of the arterial access sheath. 
     
     
         9 . A method as in  claim 8 , further the blood flows out a side opening located between the distal end and the proximal end of the arterial access sheath. 
     
     
         10 . A method as in  claim 8 , wherein the blood flows into a shunt connected to the access sheath. 
     
     
         11 . A method as in  claim 10 , further comprising fluidly connecting the shunt to a collection reservoir or a venous return site in the patient. 
     
     
         12 . A method as in  claim 8 , further comprising regulating the rate of flow from the common carotid artery. 
     
     
         13 . A method as in  claim 7 , further comprising applying aspiration to the artery through the access sheath. 
     
     
         14 . A method as in  claim 13 , further comprising regulating a rate of the aspiration. 
     
     
         15 . A method as in  claim 7 , wherein occluding the common carotid artery comprises inflating an occlusion balloon on the arterial access sheath. 
     
     
         16 . A method as in  claim 1 , wherein the internal lumen of the arterial access sheath is sized and shaped to receive a valve delivery system configured to deliver the prosthetic valve into the heart through the arterial access sheath. 
     
     
         17 . A method as in  claim 1 , wherein the embolic protection filter comprises an expandable frame and a filter material covering the frame. 
     
     
         18 . A method as in  claim 17 , wherein the filter material is a woven textile material or a knitted textile material. 
     
     
         19 . A method as in  claim 17 , wherein the filter material is a perforated polymer membrane. 
     
     
         20 . A method as in  claim 17 , wherein the filter material has a porosity that is between 40 micron porosity and 300 micron porosity. 
     
     
         21 . A method as in  claim 17 , wherein the expandable frame is formed of a spring material. 
     
     
         22 . A method as in  claim 21 , wherein the spring material is stainless steel, Nitinol wire, or Nitinol ribbon. 
     
     
         23 . A method as in  claim 17 , wherein the expandable frame is a loop having an expanded diameter between 12 mm and 30 mm. 
     
     
         24 . A method as in  claim 17 , wherein the expandable frame is formed by a series of struts connected at one or both ends of the embolic protection filter. 
     
     
         25 . A method as in  claim 1 , wherein the embolic protection filter has a cone shape or a closed-end tube shape.

Join the waitlist — get patent alerts

Track US2020375729A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.